Guido Baechler - 01 Jan 2026 Form 3 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Role: Chief Executive Officer, Director
Signature: /s/ Guido Baechler
Issuer symbol: MYNZ
Transactions as of: 01 Jan 2026
Net transactions value: $0
Form type: 3
Filing time: 26 Jan 2026, 16:02:37 UTC
Next filing: 19 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BAECHLER GUIDO	Chief Executive Officer, Director	MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ, GERMANY	/s/ Guido Baechler	26 Jan 2026	0001561662

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYNZ	Ordinary Shares						6,362	01 Jan 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MYNZ	Employee Stock Option (Right to Buy)							01 Jan 2026	Ordinary Shares	145,000	$4.95	Direct	F1
holding	MYNZ	Employee Stock Option (Right to Buy)							01 Jan 2026	Ordinary Shares	11,696	$200.00	Direct	F2
holding	MYNZ	Employee Stock Option (Right to Buy)							01 Jan 2026	Ordinary Shares	2,000	$302.80	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	50% of the option vested upon grant on 03/04/2025; the remaining balance vests 25% on 03/24/26 and 25% on 03/04/2027.
F2	Fully vested.
F3	Four-year vesting schedule: 25% vests on 12/21/2023, and the remainder vests 1/36 per month until 12/21/2026.